Gene · 200424
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma. | BMC Cancer | 2024 | 38166895 | PubTator, text mining | PubMed |
| Single-cell RNA-seq and single-cell bisulfite-sequencing reveal insights into yak preimplantation embryogenesis. | J Biol Chem | 2024 | 38097189 | PubTator, text mining | PubMed |
| Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep. | Mol Genet Genomic Med | 2024 | 38087948 | PubTator, text mining | PubMed |
| Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications. | Pathol Res Pract | 2024 | 38056136 | PubTator, text mining | PubMed |
| Association between SPRY1 and TET3 in skin photoaging and natural aging mechanisms. | J Cosmet Dermatol | 2024 | 38054565 | PubTator, text mining | PubMed |
| Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression. | Adv Sci (Weinh) | 2024 | 37985644 | PubTator, text mining | PubMed |
| IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process. | Adv Sci (Weinh) | 2024 | 37983610 | PubTator, text mining | PubMed |
| Induction of Kallikrein-Related Peptidase 13 and TET2/3 by Anticancer Drugs and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Preoperative Treatment. | Ann Surg Oncol | 2024 | 37798554 | PubTator, text mining | PubMed |
| DNA methylation clocks for clawed frogs reveal evolutionary conservation of epigenetic aging. | Geroscience | 2024 | 37270437 | PubTator, text mining | PubMed |
| Five years of experience in the Epigenetics and Chromatin Clinic: what have we learned and where do we go from here? | Hum Genet | 2024 | 36952035 | PubTator, text mining | PubMed |
| The value of genome-wide analysis in craniosynostosis. | Front Genet | 2023 | 38318288 | PubTator, text mining | PubMed |
| Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health. | Front Genet | 2023 | 38299096 | PubTator, text mining | PubMed |
| Advancing genome editing with artificial intelligence: opportunities, challenges, and future directions. | Front Bioeng Biotechnol | 2023 | 38260726 | PubTator, text mining | PubMed |
| Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia. | Biomedicines | 2023 | 38255170 | PubTator, text mining | PubMed |
| Unraveling the Epigenetic Tapestry: Decoding the Impact of Epigenetic Modifications in Hidradenitis Suppurativa Pathogenesis. | Genes (Basel) | 2023 | 38254928 | PubTator, text mining | PubMed |
| TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets. | Int J Mol Sci | 2023 | 38203443 | PubTator, text mining | PubMed |
| Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases. | J Clin Med | 2023 | 38202170 | PubTator, text mining | PubMed |
| Parental sex-dependent effects of either maternal or paternal eNOS deficiency on the offspring's phenotype without transmission of the parental eNOS deficiency to the offspring. | Front Physiol | 2023 | 38169827 | PubTator, text mining | PubMed |
| Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review. | Immun Inflamm Dis | 2023 | 38156400 | PubTator, text mining | PubMed |
| Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. | Clin Transl Med | 2023 | 38148658 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200424/papers?page=10